Project Management for Phase 3 and LCM (Life Cycle Management) of the Drug Development Process

October 18, 2012

Center for Professional Innovation & Education, Inc., King of Prussia, PA Mar 20 & 21, 2013 Speed to market is the key to driving product revenue. Managing the quality of the Phase 3 and 4 activities will impact project timing and budget and have a significant effect on the bottom line. Project managers must understand the late stage development process and the key aspects of product submission, approval and launch. Participants will learn best practices for developing and managing these trials and submissions within GCP guidelines and FDA regulations. The course will discuss the challenges associated with outsourcing, site selection, patient recruitment and data management. Clinical research that complies with international and domestic regulatory guidelines and produces high-quality data for submission is the goal. The course is interactive and designed to allow for the exchange of ideas with peers in addition to learning from the instructor.

Organized by:			Center for Professional Innovation & Education, Inc.
Invited Speakers:			Contact info@cfpie.com for a list of course instructors

Deadline for Abstracts:			n/a

Registration:			http://www.cfpie.com/showitem.aspx?productid=101&source=hummolgen
E-mail:			info@cfpie.com

events